Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-08-003840
Filing Date
2008-11-14
Accepted
2008-11-14 10:51:59
Documents
5
Period of Report
2008-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q w71559e10vq.htm 10-Q 458270
2 EXHIBIT 31.1 w71559exv31w1.htm EX-31.1 7730
3 EXHIBIT 31.2 w71559exv31w2.htm EX-31.2 7747
4 EXHIBIT 32.1 w71559exv32w1.htm EX-32.1 3114
5 EXHIBIT 32.2 w71559exv32w2.htm EX-32.2 3129
  Complete submission text file 0000950133-08-003840.txt   481376
Mailing Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 081187889
SIC: 2834 Pharmaceutical Preparations